Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VORTIOXETINE HYDROBROMIDE Cause Vision blurred? 200 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 200 reports of Vision blurred have been filed in association with VORTIOXETINE HYDROBROMIDE (Trintellix). This represents 1.5% of all adverse event reports for VORTIOXETINE HYDROBROMIDE.

200
Reports of Vision blurred with VORTIOXETINE HYDROBROMIDE
1.5%
of all VORTIOXETINE HYDROBROMIDE reports
13
Deaths
7
Hospitalizations

How Dangerous Is Vision blurred From VORTIOXETINE HYDROBROMIDE?

Of the 200 reports, 13 (6.5%) resulted in death, 7 (3.5%) required hospitalization, and 1 (0.5%) were considered life-threatening.

Is Vision blurred Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VORTIOXETINE HYDROBROMIDE. However, 200 reports have been filed with the FAERS database.

What Other Side Effects Does VORTIOXETINE HYDROBROMIDE Cause?

Nausea (2,062) Anxiety (861) Vomiting (811) Suicidal ideation (742) Headache (738) Fatigue (697) Drug ineffective (693) Pruritus (653) Insomnia (636) Feeling abnormal (620)

What Other Drugs Cause Vision blurred?

DUPILUMAB (5,564) LIFITEGRAST (2,465) ADALIMUMAB (2,347) PREGABALIN (2,095) FINGOLIMOD (2,018) CYCLOSPORINE (1,642) LENALIDOMIDE (1,434) SODIUM (1,262) GABAPENTIN (1,081) DULOXETINE (1,019)

Which VORTIOXETINE HYDROBROMIDE Alternatives Have Lower Vision blurred Risk?

VORTIOXETINE HYDROBROMIDE vs VOSORITIDE VORTIOXETINE HYDROBROMIDE vs VOTRIENT VORTIOXETINE HYDROBROMIDE vs VOXELOTOR VORTIOXETINE HYDROBROMIDE vs VUTRISIRAN VORTIOXETINE HYDROBROMIDE vs VX-950

Related Pages

VORTIOXETINE HYDROBROMIDE Full Profile All Vision blurred Reports All Drugs Causing Vision blurred VORTIOXETINE HYDROBROMIDE Demographics